Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/17342
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) |
Author: | Swiedler, S. Beck, M. Bajbouj, M. Giugliani, R. Schwartz, I. Harmatz, P. Wraith, J. Roberts, J. Ketteridge, D. Hopwood, J. Guffon, N. Miranda, C. Teles, E. Berger, K. Piscia-Nichols, C. |
Citation: | American Journal of Medical Genetics Part A, 2005; 134A(2):144-150 |
Publisher: | Wiley-Liss |
Issue Date: | 2005 |
ISSN: | 1552-4825 1552-4833 |
Statement of Responsibility: | Stuart J. Swiedler, Michael Beck, Manal Bajbouj, Roberto Giugliani, Ida Schwartz, Paul Harmatz, James E. Wraith, Jane Roberts, David Ketteridge, John J. Hopwood, Nathalie Guffon, M. Clara Sá Miranda, Elisa Leão Teles, Kenneth I. Berger, Cheri Piscia-Nichols |
Abstract: | A cross-sectional survey in individuals affected with the lysosomal storage disease Mucopolysaccharidosis VI (MPS VI) was conducted to establish demographics, urinary glycosaminoglycan (GAG) levels, and clinical progression of the disease. The survey evaluated 121 bona fide MPS VI-affected individuals over the age of 4 years from 15 countries across the Americas, Europe, and Australasia representing greater than 10% of the estimated world prevalence of the disease. A medical history, complete physical exam, urinary GAG determination, and assessment of several clinical measures related to physical endurance, pulmonary function, joint range of motion, strength, and quality of life were completed for each participant. Although a wide variation in clinical presentation was observed, several general findings were obtained reflecting progression of the disease. Impaired physical endurance, as measured by the distance achieved in a 6-min walk, could be demonstrated across all age groups of MPS VI-affected individuals. High urinary GAG values (>200 mug/mg creatinine) were associated with an accelerated clinical course comprised of age-adjusted short stature and low body weight, impaired endurance, compromised pulmonary function, and reduced joint range of motion. An unexpected result was the predominance of urinary GAG values <100 mug/mg creatinine for those participants over the age of 20 years. Pending the collection of longitudinal data, these results suggest that urinary GAG levels predict clinical morbidity, and longer-term survival is associated with urinary GAG levels below a threshold of 100 mug/mg creatinine. |
Keywords: | Humans Mucopolysaccharidosis VI Disease Progression Glycosaminoglycans Heart Function Tests Respiratory Function Tests Range of Motion, Articular Walking Health Surveys Data Interpretation, Statistical Cross-Sectional Studies Visual Acuity Quality of Life Adolescent Adult Middle Aged Child Child, Preschool Female Male Surveys and Questionnaires |
Rights: | © 2009 Wiley-Liss, Inc., A Wiley Company |
DOI: | 10.1002/ajmg.a.30579 |
Published version: | http://dx.doi.org/10.1002/ajmg.a.30579 |
Appears in Collections: | Aurora harvest 6 Paediatrics publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.